key: cord-1044490-db28aepb
authors: Román, Gustavo C; Reis, Jacques; Spencer, Peter S; Buguet, Alain; Öztürk, Serefnur; Wasay, Mohammad
title: COVID-19 international neurological registries
date: 2020-05-26
journal: Lancet Neurol
DOI: 10.1016/s1474-4422(20)30148-4
sha: 2452232037ac235f2dc26fa6b0721d0a0df9824e
doc_id: 1044490
cord_uid: db28aepb

nan

reported on 214 patients who were admitted to hospital in Wuhan, China, with acute COVID-19. Symptoms were severe in 59% (mean age 58·7 years) of these patients, and non-severe in 41% (mean age 49·9 years). In total, 78 (36%) of 214 patients had neurological compromise, which was more common in severe (46%) than in non-severe (30%) cases and included stroke, impaired consciousness, myopathy, and neu ralgic pain. Viral meningo encephalitis with presence of SARS-CoV-2 in CSF by viral genome sequencing has been reported in patients in China 3 and Japan. 4 In the USA, a woman aged between 50 and 60 years developed COVID-19 and altered mental status. Brain MRI on this patient showed bilateral haemorrhagic rim-enhancing lesions within thalami, medial tem poral lobes, and subinsular regions char acteristic of acute haemorrhagic necrotis ing encephalopathy. 5 This con dition also, but rarely, occurs in influenza and other encephali tides in association with cytokine storm syndrome.

Amid confronting a severe out break of COVID-19, the Spanish Neurological Society (Sociedad Española de Neurología) implemented a registry of neuro logical manifestations in patients with confirmed COVID-19. We applaud this initiative and propose to expand these efforts globally to define the nervous system involvement in COVID-19. The Environmental Neurology Specialty Group of the World Federation of Neurology (ENSG-WFN) is encouraging neurological soci eties around the world to develop national or regional neuroepidemiological data banks to report all cases of new-onset, acute, delayed, and any long-latency neurological disorders associ ated with SARS-CoV-2 infection during the COVID-19 pandemic. Late parkinsonism occurred among survivors of the 1918-20 influenza pandemic. Therefore, neurologists must be prepared for the occurrence of delayed neurological manifestations of COVID-19. 

The pandemic of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already affected more than 2·7 million people and caused more than 192 000 deaths worldwide. Respiratory symptoms are the most common, and neurogenic breathing failure is suspected to be involved. 1 Symptoms such as anosmia, dysgeusia, headache, and muscle pain have been noted, along with reports of central and peri pheral nervous system involvement. Mao The worldwide response to the pandemic indicates that neurologists and other physicians, govern ment authorities, and scientists with expertise in public health, epi demiology, infectious diseases, virol ogy, and other relevant fields will be will ing to advise and assist their local neurological societies to create databases of neurological manifestations related to COVID-19. These databases will also encourage much needed peer-reviewed publications of the neurological implications of the pandemic. The ENSG-WFN will work to assure that the results of the national and regional registries are collected, posted, and become freely available on the WFN website. This global effort should help develop an understanding of the neurological impact of COVID-19.

The members of the World Federation of Neurology Environmental Neurology Specialty Group and their affiliations are listed in the appendix. All authors are

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Neurologic manifestations of hospitalized patients with coronavirus disease

Nervous system involvement after infection with COVID-19 and other coronaviruses

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features

Environmental Neurology Specialty Group of the World Federation of Neurology and declare no competing interests